| RESEARCH |
Pharmacopeia shifts R&D Pharmacopeia will reorganize R&D at its Accelrys molecular modeling and informatics unit, moving all bioinformatics work to its Bangalore, India, facility; all materials science work to its Cambridge, England, facility; and all chemical informatics to its site in San Diego. There will be unspecified staff reductions in San Diego, its largest facility, but the company plans to increase worldwide R&D staff by 20%, according to Chief Financial Officer John J. Hanlon. The moves, he says, will generate annual savings of up to $2 million. Meanwhile, the company is consolidating research at Pharmacopeia Drug Discovery to one of two labs in Princeton, N.J., saving about $2 million per year. Hanlon says the firm is on schedule to spin off PDD next month (C&EN, Jan. 5, page 13). |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |